Keyword: Eisai

Markets & Companies

Navigating Uncertainty in the Biopharma Market

17.05.2023 -

Biopharma companies are facing funding challenges in 2023 as interest rates rise and investors are becoming more risk adverse. There is hope on the horizon, say some...

News

Japan’s Eisai Gets EU Nod for Thyroid Cancer Drug

31.03.2015 - The EU's Committee for Medicinal Products for Human Use (CHMP) has recommended the use of Eisai's Lenvima (Lenvatinib mesylate) drug for treating adults with progressive, locally...

News

Eisai Pulls Fycompa from German Market after Pricing Tiff

26.06.2013 - Japanese drugmaker Eisai is to stop selling its new epilepsy therapy Fycompa in Germany - the biggest market for the product - following a row over the price it can charge for the...

News

DSM Signs Master Supply Agreement with Eisai

06.03.2013 - DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, today announced the signing of a 3 year master supply agreement with Eisai, based in...

News

GSK and J&J Lead Rivals in Drug Access for Poor

28.11.2012 - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...

News

FDA OKs First Obesity Drug in 13 years

28.06.2012 - U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals to bring its Belviq pill to market as public health advocates push for...

News

White Knight Could Be Elusive For Genzyme

02.08.2010 - Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...